Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 26

Sort by

Sort Order Select

Journal Articles

Refining Prognostication in Peripheral T Cell Lymphoma (PTCL): A Risk-Adapted Prognostic Model for Patients with Limited-Stage PTCL

Carolina Romero, Macarena Roa, Henry Idrobo, Denisse Castro, Brady E Beltran, Daniel J Enriquez, Jule F Vasquez, Claudia Roche, Daniel Artiles, Fabiola Valvert, Luis Mario Villela Martinez, Juliana Pereira, Ana Carolina Oliver, Jamila Vaz Tavarez, Sergio Augusto B Brasil, Karin Z Cecyn, Nelson S Castro, Renata Lyrio R Baptista, Samuel S. Medina, Davimar Miranda Maciel Borducchi, Marcelo Bellesso, Danielle Leão Cordeiro De Farias, Yung Gonzaga, Laura Korin, Patricio Pereyra, Camila Peña, Maria Alejandra Torres Viera, Kelly Meza, Seisha Von Glasenapp, Alfredo Quiroz, Cesar Samanez-Figari, Rosa Oliday Rios Jimenez, Sally Paredes, Thais Fischer, Asaad Trabolsi, Jonathan H. Schatz, Swaminathan P Iyer, Ranjit Nair, Eduardo Edelman Saul, Casey Bermack, Jorge J. Castillo, Carmino De Souza, Eliana Miranda, Bryan Valcarcel, Carlos Chiattone, Luis Enrique Malpica Castillo

Blood (2024) 144 (Supplement 1): 983.

https://doi.org/10.1182/blood-2024-205295

Published: 2024

Journal Articles

Uncovering the Epidemiology, Therapy Patterns and Outcomes of MALT Lymphoma in Latin America: A Multinational Retrospective Cohort Study

Blood (2024) 144 (Supplement 1): 3718.

https://doi.org/10.1182/blood-2024-204266

Published: 2024

Journal Articles

Clinical Features, Therapy Patterns and Survival Outcomes of Limited-Stage Peripheral T-Cell Lymphomas: A Cross-Continental Study

Juan Esteban Garcia-Robledo, Henry Quintero, Denisse Castro, Brady E Beltran, Daniel J Enriquez, Jule F Vasquez, Claudia Roche, Daniel Artiles, Fabiola Valvert, Luis Mario Villela Martinez, Juliana Pereira, Ana Carolina Oliver, Jamila Vaz Tavarez, Sergio Augusto B Brasil, Karin Z Cecyn, Nelson S Castro, Renata Lyrio R Baptista, Samuel S. Medina, Davimar Miranda Maciel Borducchi, Marcelo Bellesso, Danielle Leão Cordeiro De Farias, Yung Gonzaga, Laura Korin, Patricio Pereyra, Camila Peña, Macarena Roa, Maria Alejandra Torres Viera, Kelly Meza, Seisha Von Glasenapp, Alfredo Quiroz, Cesar Samanez-Figari, Rosa Oliday Rios Jimenez, Sally Paredes, Thais Fischer, Asaad Trabolsi, Jonathan H. Schatz, Swaminathan P Iyer, Ranjit Nair, Eduardo Edelman Saul, Casey Bermack, Jorge J. Castillo, Carmino De Souza, Eliana Miranda, Bryan Valcarcel, Carlos Chiattone, Luis Enrique Malpica Castillo

Blood (2024) 144 (Supplement 1): 1687.

https://doi.org/10.1182/blood-2024-205881

Published: 2024

Journal Articles

Selection of CUT-Off Points for Prognostic Biomarkers in Lymphoma Using Restricted Cubic Splines: Experience of the Grupo De Estudio De Linfoproliferativos De Latinoamérica (GELL) in a Cohort of Diffuse Large B-Cell Lymphoma Patients

Blood (2024) 144 (Supplement 1): 6452.

https://doi.org/10.1182/blood-2024-198823

Published: 2024

Journal Articles

Dose-Response Relationship between Inflammatory Biomarkers and Overall Survival Using Restricted Cubic Splines: Experience of the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) in a Cohort of Diffuse Large B-Cell Lymphoma

Blood (2024) 144 (Supplement 1): 6474.

https://doi.org/10.1182/blood-2024-209615

Published: 2024

Journal Articles

Extranodal NK/T-Cell Lymphoma in Latin America: A Retrospective Multinational Analysis of Clinical Features, Therapeutic Approaches and Outcomes from the Latin American Group of Lymphoproliferative Disorders (GELL)

Fabiola Valvert, Omar Eduardo Fernandez Vargas, Sally Paredes, Luís Alberto de Pádua Covas Lage, Luis Mario Villela Martinez, Jose Marcial Macias Abasto, Victoria Irigoin, Cesar Camilo Carias Alvado, Juan C Barrios, Brenda Lizeth Acosta Maldonado, Denisse Castro, Betty Ramos Condori, Juliana Pereira, Silvia Rivas-Vera, Brady Beltran, Luis Malpica

Blood (2024) 144 (Supplement 1): 4452.

https://doi.org/10.1182/blood-2024-211049

Published: 2024

Journal Articles

Leveraging a Novel Machine Learning Method to Predict Outcomes in Latin American (LATAM) Patients with Newly Diagnosed T and NK Cell Lymphomas (TNKL)

Blood (2024) 144 (Supplement 1): 7515.

https://doi.org/10.1182/blood-2024-208856

Published: 2024

Journal Articles

Primary CNS Lymphoma in Latin America: A Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) Survey in 80 Cancer Centers in Latin America

Blood (2023) 142 (Supplement 1): 2422.

https://doi.org/10.1182/blood-2023-190477

Published: 2023

Journal Articles

Validating the Halp Score (Hemoglobin,Albumin, Lymphocytes, and Platelets) and the Neutrophil/Lymphocyte Ratio ( NLR ) As Prognostic Factors for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma. Retrospective Analysis By the Grupo De Estudio De Latino America De Linfoproliferativos (GELL)

Blood (2023) 142 (Supplement 1): 1757.

https://doi.org/10.1182/blood-2023-188265

Published: 2023

Journal Articles

Epidemiology, Clinical Features and Outcomes of Peripheral T-Cell Lymphoma in Latin America

Thais Fischer, Henry Idrobo, Astrid Pavlovsky, Denisse Castro, Brady Beltran, Daniel J Enriquez, Jule F Vasquez, Claudia Roche, Daniel Artiles, Fabiola Valvert, Luis Mario Villela, Juliana Pereira, Carolina Oliver, Jamila Vaz Tavarez, Sergio Augusto B Brasil, Karin Z Cecyn, Nelson Castro, Renata Baptista, Samuel de S Medina, Davimar Miranda Maciel Borducchi, Marcelo Bellesso, Danielle Leao Cordeiro De Farias, Yung Bruno Gonzaga, Fernando Warley, Lorena Fiad, Laura Korin, Patricio Hernan Pereyra, Camila Peña, Maria Alejandra Torres, Carolina Valeria Mahuad, Alana Von Glasenapp, Alfredo Reinaldo Quiroz, Raimundo Gazitua, Cesar Augusto Samanez-Figari, Lautaro Sardu, Juan Pablo Arriola, Sebastian Isnardi, Juan L. Maradei, Raul Hector Gabus, Alicia I. Enrico, Luciana A Guanchiale, Florencia Negri Arangueren, Juan Ignacio García Altuve, Amalia Cerutti, Romina Penalva, Jose Ignacio Garcia Trucco, Florencia Pessolani, Virginia Gilli, Joaquin Diaz, Maria Enriqueta Martinez, Gustavo Jarchum, Gabriela Celia Perinotto, Teresa Barraza, Sergio Ciarlo, Christine Rojas, Rosa Oliday Rios Jiménez, Carmino De Souza, Martina Manni, Eliana C M CM Miranda, Massimo Federico, Bryan Valcarcel, Carlos Chiattone, Luis Enrique Malpica Castillo

Blood (2023) 142 (Supplement 1): 186.

https://doi.org/10.1182/blood-2023-187254

Published: 2023

Journal Articles

Validating the Systemic Inmmune-Inflamation Index (SII) As a Prognostic Biomarker of Overall Survival in Diffuse Large B-Cell Lymphoma: A Retrospective Analyses By the Gruppo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2023) 142 (Supplement 1): 1775.

https://doi.org/10.1182/blood-2023-188015

Published: 2023

Journal Articles

Validating the Prognostic Value of Anemia and Thrombocytopenia in Latin American Patients with Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2022) 140 (Supplement 1): 6708–6710.

https://doi.org/10.1182/blood-2022-168165

Published: 2022

Journal Articles

Serum Albumin and Neutrophil-to-Lymphocyte Ratio, Two Independent Factor Predicting Survival in Patients with Follicular Lymphoma: A Multi-Institutional Retrospective Cohort of 741 FL, from the Latin American Lymphoproliferative Study Group (GELL)

Blood (2021) 138 (Supplement 1): 4515.

https://doi.org/10.1182/blood-2021-149662

Published: 2021

Journal Articles

A Novel Prognostic Index for Patients with EBV-DLBCL NOS: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2021) 138 (Supplement 1): 1436.

https://doi.org/10.1182/blood-2021-151389

Published: 2021

Journal Articles

Clinicopathological Features and Outcomes of EBV Positive and Negative DLBCL: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2021) 138 (Supplement 1): 1442.

https://doi.org/10.1182/blood-2021-152340

Published: 2021

Journal Articles

Updated Analysis Confirms Sustained Poor Prognosis of COVID-19 in Patients with Lymphoma in Latin America: A Cohort of 160 Patients from Gell

Blood (2021) 138 (Supplement 1): 2520.

https://doi.org/10.1182/blood-2021-153875

Published: 2021

Journal Articles

Biological and Classical Prognostic Factors with Impact on Overall Survival in Patients with Early Stage (I/II) Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Blood (2021) 138 (Supplement 1): 2516.

https://doi.org/10.1182/blood-2021-152724

Published: 2021

Journal Articles

Epidemiology, Clinical Features, and Outcome of HTLV-1-Related Adult T-Cell Leukemia/Lymphoma in Latin America: A Study from the Latin American Group of Lymphoproliferative Disorders (GELL)

Blood (2020) 136 (Supplement 1): 18–21.

https://doi.org/10.1182/blood-2020-140630

Published: 2020

Journal Articles

Proposal of a Novel Latin American International Prognostic Index (LATAM-IPI) for Diffuse Large B-Cell Lymphoma (DLBCL) By the Grupo Para El Estudio De Linfoproliferativos En Latino-America (GELL)

Luis Villela Villela, MDMC, Ana Ramirez-Ibarguen, MD, Brady E Beltran, MD, Camila Peña, MD, Denisse A. Castro, MD, Gladys P Agreda-Vasquez, MD, Myrna Candelaria, MDPharmD, Maria Alejandra Torres Viera, MD, Henry Idrobo, MD, Lorena Fiad, MD, Fabiola Valvert, MD, Efreen Montaño Figueroa, MD PhD, Juan Ospina Idarraga, Alana Von Glasenapp, MD, Sally Paredes, MD, Melani Otañez, MD, Fernando Perez-Jacobo, Daniela Zambrano, Humberto Martínez Cordero, MD, Virginia Otero, MD, Lidiane Andino, Mercedes Royg Arriola, MD, Maria Elvira Enciso, MD, Maria Prates, MD, Cristaldo Nancy, MD, Ivan Perdomo, MD, Maria E Cabrera, MD, María Lorena Cardozo, MD, Cristobal Augusto Frutos Ortiz, MD, Eloisa Riva, MD, Juan Antonio Choque, MD, Alfredo Reinaldo Quiroz, MD, Guilherme Fleury Perini, MD, David Gomez-Almaguer, MD, Guillermo J. Ruiz-Arguelles, FRCP, MACP, Marcos Distefano, Katerine Garcia, Carolina Feres, MD, Mariana Kalmus, Julian Cordova, Magali DelosRios, MD, Rosio Baena, MD, Luis Malpica Castillo, MD, Eduardo Sotomayor, MD, Jorge J. Castillo, MD

Blood (2020) 136 (Supplement 1): 25–27.

https://doi.org/10.1182/blood-2020-142836

Published: 2020

Journal Articles

Follicular Lymphoma in Latin America: Real-World Experience from 763 Patients

Blood (2020) 136 (Supplement 1): 12–13.

https://doi.org/10.1182/blood-2020-141943

Published: 2020

NARROW

Refining Prognostication in Peripheral T Cell Lymphoma (PTCL): A Risk-Adapted Prognostic Model for Patients with Limited-Stage PTCL

Uncovering the Epidemiology, Therapy Patterns and Outcomes of MALT Lymphoma in Latin America: A Multinational Retrospective Cohort Study

Clinical Features, Therapy Patterns and Survival Outcomes of Limited-Stage Peripheral T-Cell Lymphomas: A Cross-Continental Study

Selection of CUT-Off Points for Prognostic Biomarkers in Lymphoma Using Restricted Cubic Splines: Experience of the Grupo De Estudio De Linfoproliferativos De Latinoamérica (GELL) in a Cohort of Diffuse Large B-Cell Lymphoma Patients

Dose-Response Relationship between Inflammatory Biomarkers and Overall Survival Using Restricted Cubic Splines: Experience of the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) in a Cohort of Diffuse Large B-Cell Lymphoma

Extranodal NK/T-Cell Lymphoma in Latin America: A Retrospective Multinational Analysis of Clinical Features, Therapeutic Approaches and Outcomes from the Latin American Group of Lymphoproliferative Disorders (GELL)

Leveraging a Novel Machine Learning Method to Predict Outcomes in Latin American (LATAM) Patients with Newly Diagnosed T and NK Cell Lymphomas (TNKL)

Primary CNS Lymphoma in Latin America: A Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL) Survey in 80 Cancer Centers in Latin America

Epidemiology, Clinical Features and Outcomes of Peripheral T-Cell Lymphoma in Latin America

Validating the Systemic Inmmune-Inflamation Index (SII) As a Prognostic Biomarker of Overall Survival in Diffuse Large B-Cell Lymphoma: A Retrospective Analyses By the Gruppo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Validating the Prognostic Value of Anemia and Thrombocytopenia in Latin American Patients with Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Serum Albumin and Neutrophil-to-Lymphocyte Ratio, Two Independent Factor Predicting Survival in Patients with Follicular Lymphoma: A Multi-Institutional Retrospective Cohort of 741 FL, from the Latin American Lymphoproliferative Study Group (GELL)

A Novel Prognostic Index for Patients with EBV-DLBCL NOS: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Clinicopathological Features and Outcomes of EBV Positive and Negative DLBCL: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Updated Analysis Confirms Sustained Poor Prognosis of COVID-19 in Patients with Lymphoma in Latin America: A Cohort of 160 Patients from Gell

Biological and Classical Prognostic Factors with Impact on Overall Survival in Patients with Early Stage (I/II) Diffuse Large B-Cell Lymphoma: A Study from the Grupo De Estudio Latinoamericano De Linfoproliferativos (GELL)

Epidemiology, Clinical Features, and Outcome of HTLV-1-Related Adult T-Cell Leukemia/Lymphoma in Latin America: A Study from the Latin American Group of Lymphoproliferative Disorders (GELL)

Proposal of a Novel Latin American International Prognostic Index (LATAM-IPI) for Diffuse Large B-Cell Lymphoma (DLBCL) By the Grupo Para El Estudio De Linfoproliferativos En Latino-America (GELL)

Follicular Lymphoma in Latin America: Real-World Experience from 763 Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only